Velan Capital Investment Management Lp
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$159.6M
Q ending 2026-03-31
Prior quarter
$172.4M
Q ending 2025-12-31
Change
-7.4% QoQ · +64.2% YoY
Positions
49
reported holdings
Largest positions
All 49 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Praxis Precision Medicines I | PRAX | Shares | $32.5M | 101K |
| Protara Therapeutics Inc | TARA | Shares | $14.8M | 2.8M |
| Sutro Biopharma Inc | STRO | Shares | $12.8M | 512K |
| Evommune Inc | EVMN | Shares | $10.3M | 446K |
| Maplight Therapeutics Inc | MPLT | Shares | $10.0M | 493K |
| Tenax Therapeutics Inc | TENX | Shares | $9.3M | 583K |
| Abivax Sa | ABVX | Shares | $8.6M | 77K |
| Heron Therapeutics Inc | HRTX | Shares | $7.0M | 8.8M |
| Immix Biopharma Inc | IMMX | Shares | $6.7M | 740K |
| Esperion Therapeutics Inc Ne | Shares | $4.7M | 1.7M | |
| Edesa Biotech Inc | EDSA | Shares | $4.3M | 828K |
| Anteris Technologies Global | AVR | Shares | $3.9M | 700K |
| Inspiremd Inc | NSPR | Shares | $3.4M | 2.1M |
| Xencor Inc | XNCR | Shares | $3.0M | 250K |
| Avalo Therapeutics Inc | AVTX | Shares | $2.8M | 185K |
| Eupraxia Pharmaceuticals Inc | EPRX | Shares | $2.5M | 352K |
| Cytomx Therapeutics Inc. | CTMX | Shares | $2.5M | 540K |
| Verrica Pharmaceuticals Inc | VRCA | Shares | $2.5M | 472K |
| Jasper Therapeutics Inc | JSPR | Shares | $2.3M | 2.7M |
| Rezolute Inc | RZLT | Shares | $2.3M | 750K |
| Lyell Immunopharma Inc | LYEL | Shares | $2.0M | 102K |
| Profound Med Corp | PROF | Shares | $1.9M | 286K |
| Viridian Therapeutics Inc | VRDN | Shares | $1.8M | 91K |
| Rocket Pharmaceuticals Inc | RCKT | Shares | $1.1M | 295K |
| Kazia Therapeutics Ltd | KZIA | Shares | $1.0M | 135K |
| Nasus Pharma Ltd | Shares | $798K | 359K | |
| Quoin Pharmaceuticals Ltd | QNRX | Shares | $560K | 85K |
| Arrowhead Pharmaceuticals In | ARWR | Shares | $408K | 7K |
| Protagonist Therapeutics Inc | PTGX | Shares | $390K | 4K |
| Ovid Therapeutics Inc | OVID | Shares | $355K | 160K |
| Mineralys Therapeutics Inc | MLYS | Shares | $298K | 11K |
| Context Therapeutics Inc | CNTX | Shares | $262K | 100K |
| Nurix Therapeutics Inc | NRIX | Shares | $248K | 16K |
| Corbus Pharmaceuticals Hldgs | CRBP | Shares | $244K | 26K |
| Syndax Pharmaceuticals Inc | SNDX | Shares | $234K | 10K |
| Precision Biosciences Inc | DTIL | Shares | $220K | 40K |
| Immunome Inc | IMNM | Shares | $219K | 10K |
| Design Therapeutics Inc | DSGN | Shares | $213K | 20K |
| Artiva Biotherapeutics Inc | ARTV | Shares | $161K | 25K |
| Neumora Therapeutics Inc. | NMRA | Shares | $156K | 80K |
| Replimune Group Inc | REPL | Shares | $153K | 20K |
| Larimar Therapeutics Inc | LRMR | Shares | $149K | 33K |
| Xilio Therapeutics Inc | XLO | Shares | $120K | 14K |
| Kalaris Therapeutics Inc | KLRS | Shares | $104K | 18K |
| Pmv Pharmaceuticals Inc | PMVP | Shares | $91K | 73K |
| Macrogenics Inc | MGNX | Shares | $87K | 30K |
| Karyopharm Therapeutics Inc | KPTI | Shares | $84K | 15K |
| Proqr Thrapeutics N V | Shares | $73K | 45K | |
| Gossamer Bio Inc | GOSS | Shares | $23K | 70K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.